Holen Sie sich die Stockscreener-App
0.785
1.01%
-0.008
Handel nachbörslich:
.77
-0.015
-1.91%
Schlusskurs vom Vortag:
$0.793
Offen:
$0.7857
24-Stunden-Volumen:
148.53K
Relative Volume:
0.50
Marktkapitalisierung:
$60.32M
Einnahmen:
$9.53M
Nettoeinkommen (Verlust:
$-44.61M
KGV:
-0.8626
EPS:
-0.91
Netto-Cashflow:
$-38.32M
1W Leistung:
-2.06%
1M Leistung:
+3.02%
6M Leistung:
-32.91%
1J Leistung:
+18.80%
1-Tages-Spanne:
$0.77
$0.79
1-Wochen-Bereich:
$0.77
$0.81
52-Wochen-Spanne:
$0.45
$1.9891
Cue Biopharma Inc Stock (CUE) Company Profile
Firmenname
Cue Biopharma Inc
Sektor
Branche
Telefon
617-949-2680
Adresse
40 GUEST STREET, BOSTON, MA
Vergleichen Sie CUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.785 | 60.94M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-11-21 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-03 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-04-09 | Eingeleitet | Stifel | Buy |
| 2020-01-28 | Eingeleitet | BTIG Research | Buy |
| 2020-01-22 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Cue Biopharma Inc Aktie (CUE) Neueste Nachrichten
Cue Biopharma Inc. stock trend forecast2025 Retail Activity & Free Accurate Trade Setup Notifications - Newser
How to track smart money flows in Cue Biopharma Inc.2025 Year in Review & Low Risk High Reward Trade Ideas - Newser
Cue Biopharma Inc. Approaches Psychological Resistance Level2025 Technical Overview & Daily Entry Point Trade Alerts - beatles.ru
When is the best time to exit Cue Biopharma Inc.Weekly Loss Report & Daily Momentum Trading Reports - Newser
Can Cue Biopharma Inc. disrupt its industryGDP Growth & Risk Controlled Stock Pick Alerts - khodrobank.com
Insider Sell: Can Cue Biopharma Inc. navigate macro headwindsFed Meeting & Free Verified High Yield Trade Plans - khodrobank.com
Does Cue Biopharma Inc. meet Warren Buffett’s criteria2025 Geopolitical Influence & Safe Swing Trade Setups - khodrobank.com
Visualizing Cue Biopharma Inc. stock with heatmapsJuly 2025 Breakouts & Technical Buy Zone Confirmations - Newser
Is Cue Biopharma Inc. forming a double bottom2025 Retail Activity & Precise Swing Trade Alerts - khodrobank.com
Why Cue Biopharma Inc. is moving todayIndex Update & Risk Controlled Swing Trade Alerts - Newser
Will Cue Biopharma Inc. benefit from macro trendsPortfolio Performance Report & Daily Profit Focused Stock Screening - Newser
Is Cue Biopharma Inc. likely to announce a buybackJuly 2025 Update & Growth Focused Entry Reports - khodrobank.com
Tools to assess Cue Biopharma Inc.’s risk profile2025 Earnings Impact & Community Verified Swing Trade Signals - Newser
What institutional flow reveals about Cue Biopharma Inc.Market Movers & Free Real-Time Volume Trigger Notifications - Newser
Can Cue Biopharma Inc. rally from current levelsJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
Will Volume Confirm Reversal in Cue Biopharma Inc.Portfolio Gains Summary & Pattern Based Trade Signal System - beatles.ru
Key resistance and support levels for Cue Biopharma Inc.Product Launch & Free Community Supported Trade Ideas - Newser
Will Cue Biopharma Inc. outperform during market rallies2025 Historical Comparison & Weekly Stock Performance Updates - khodrobank.com
How to escape a deep drawdown in Cue Biopharma Inc.Portfolio Risk Report & Comprehensive Market Scan Insights - Newser
What is Cue Biopharma Inc. s 5 year growth outlook2025 Technical Overview & Daily Volume Surge Trade Alerts - khodrobank.com
Real time alert setup for Cue Biopharma Inc. performance2025 AllTime Highs & Detailed Earnings Play Strategies - Newser
Is Cue Biopharma Inc. stock overvalued or fairly pricedJuly 2025 Highlights & Low Risk High Reward Ideas - khodrobank.com
Is Cue Biopharma Inc. vulnerable to short sellersForecast Cut & Low Volatility Stock Recommendations - khodrobank.com
Does Cue Biopharma Inc. fit your quant trading modelWeekly Market Outlook & Entry Point Confirmation Signals - Newser
Aug Breakouts: How much upside does Cue Biopharma Inc. haveJuly 2025 Review & Stepwise Trade Signal Guides - khodrobank.com
What is Cue Biopharma Inc. s revenue forecast2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Cue Biopharma Inc. stock daily chart insights2025 Year in Review & Stock Portfolio Risk Control - Newser
Analyzing recovery setups for Cue Biopharma Inc. investorsBuy Signal & Verified Swing Trading Watchlists - Newser
Will Cue Biopharma Inc. stock benefit from interest rate changesEarnings Performance Report & Weekly High Return Stock Opportunities - Newser
Is Cue Biopharma Inc. stock entering bullish territory2025 Trade Ideas & High Win Rate Trade Tips - Newser
Is Cue Biopharma Inc. forming a bottoming baseJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - Newser
Real time scanner hits for Cue Biopharma Inc. explainedTrade Risk Summary & Short-Term High Return Ideas - Newser
Is Cue Biopharma Inc. meeting your algorithmic filter criteriaMarket Trend Report & Real-Time Price Movement Reports - Newser
Cue Biopharma Inc. Moves Into Bullish Territory Based on MACD getLinesFromResByArray error: size == 0 - 강소기업뉴스
Why Cue Biopharma Inc. stock is on top investor watchlistsJuly 2025 EndofMonth & Safe Capital Growth Tips - Newser
How Cue Biopharma Inc. stock performs during market volatilityWeekly Trend Recap & Technical Analysis for Trade Confirmation - Newser
Will Cue Biopharma Inc. bounce back from current supportDollar Strength & Growth Focused Investment Plans - Newser
Finanzdaten der Cue Biopharma Inc-Aktie (CUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):